ACELYRIN recently completed a positive end of Phase 2 (EOP2) interaction with the U.S. Food and Drug Administration (FDA), achieving alignment on important elements of the ... reports filed with the ...

Multi-element chemistry is analyzed by 4-Acid digestion ... The CIM Standards differ from the mineral property disclosure requirements of the U.S. Securities and Exchange Commission (the "SEC”) in ...

Recent periods of financial stress and the proliferation of risks across the financial system are fueling the development of ...

Klarna, which is known for its popular “buy now, pay later” business, has filed IPO documents with the U.S. Securities and ...

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results ...

The Notes will bear interest at a rate of 2.25% per year, payable semiannually in arrears on May 1 and November 1 of each year, beginning on May 1, 2025. The Notes will mature on November 1, 2030, ...

DAVID GARFINKLE, EVP & Chief Financial Officer at CoreCivic CXW, disclosed an insider sell on November 12, according to a recent SEC filing. What Happened: According to a Form 4 filing with the U.S.

SIFMA and EY Publish U.S. Treasury Clearing Compliance Considerations Report to Guide Industry Transition to Central Clearing ...

Tokyo Lifestyle Co., Ltd. (“Tokyo Lifestyle” or the “Company”) (Nasdaq: TKLF), a retailer and wholesaler of Japanese beauty and health products, sundry products, luxury products, electronic products, ...

Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering treatments for genetically defined cardiovascular diseases and APOE4-associated Alzheimer’s ...